SOPHiA GENETICS to Present at the J.P. Morgan 2024 Healthcare Conference
BOSTON and ROLLE, Switzerland, Dec. 14, 2023 (GLOBE NEWSWIRE) — SOPHiA GENETICS (NASDAQ:SOPH) today announced that Jurgi Camblong, PhD., Chief Executive Officer and Co-founder, is scheduled to present at the J.P. Morgan 2024 Healthcare Conference on Thursday, January 11, 2024, at 9:00 a.m. PST in San Francisco.
Related news for (SOPH)
- Molecules, Machines & Markets: Biotech Booms, AI Accelerates, and Pain Relief Gets Personal
- SOPHiA GENETICS and AstraZeneca Spain Commit to Increasing Ovarian Cancer Testing in Spain
- SOPHiA GENETICS Supports Genetic Testing in Brazil
- SOPHiA GENETICS Enhances RareCyte Precision Biology Services Portfolio
